Current rheumatology reportsHumansAntiphospholipid SyndromePregnancyFemaleAntibodies
Development of 2023 ACR/EULAR Antiphospholipid Syndrome Classification Criteria, Phase III-A/B Report: Defining and Structuring the Clinical and Laboratory Domains.
Medha Barbhaiya, Stephane Zuily, Mary-Carmen Amigo, Tadej Avcin, Maria Laura Bertolaccini, D Ware Branch, Guilherme Ramires de Jesus, Katrien M J Devreese, Camille Frances, David Garcia, Francis Guillemin, Steven R Levine, Roger A Levy, Michael D Lockshin, Thomas L Ortel
Published: 202510.1007/s11926-025-01202-y
Abstract
PURPOSE OF REVIEW: An international multi-disciplinary initiative resulted in the development of 2023 ACR/EULAR Antiphospholipid Syndrome (APS) Classification Criteria to identify patients with high likelihood of APS for research. Phase I/II resulted…
Preview only. Read the full abstract at the source